ID: ALA1160829

Max Phase: Preclinical

Molecular Formula: C7H12O7

Molecular Weight: 208.17

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)[C@H]1OC(CO)C(O)C(O)C1O

Standard InChI:  InChI=1S/C7H12O7/c8-1-2-3(9)4(10)5(11)6(14-2)7(12)13/h2-6,8-11H,1H2,(H,12,13)/t2?,3?,4?,5?,6-/m0/s1

Standard InChI Key:  MTNHERCZHBRCJQ-IHVYINHVSA-N

Associated Targets(Human)

Brain glycogen phosphorylase 474 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 208.17Molecular Weight (Monoisotopic): 208.0583AlogP: -3.09#Rotatable Bonds: 2
Polar Surface Area: 127.45Molecular Species: ACIDHBA: 6HBD: 5
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.34CX Basic pKa: CX LogP: -2.88CX LogD: -6.30
Aromatic Rings: 0Heavy Atoms: 14QED Weighted: 0.33Np Likeness Score: 2.21

References

1. Pan D, Liu J, Senese C, Hopfinger AJ, Tseng Y..  (2004)  Characterization of a ligand-receptor binding event using receptor-dependent four-dimensional quantitative structure-activity relationship analysis.,  47  (12): [PMID:15163189] [10.1021/jm030586a]

Source